The JCA is live

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/90/22/1a/90221aad-9b3d-59dc-87ee-1e482d6044f3/mza_8352392173652811543.jpg/600x600bb.jpg

P4A Let's Talk Rare: The Life Science Podcast

Partners4Access

104 episodes

1 week ago

Welcome to P4A Let’s Talk Rare, a monthly podcast highlighting the most important developments in the world of rare diseases orphan drug, cell and gene therapy, hosted by Georgie Rack and Owen Bryant of Partners For Access. To find out more about Partners For Access and our commitment to sustainable orphan drug access for patients with high unmet need, visit partners4access.com

Science

RSS

All content for P4A Let's Talk Rare: The Life Science Podcast is the property of Partners4Access and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/654908/654908-1736771668196-21aa6ce03d702.jpg

The JCA is live

P4A Let's Talk Rare: The Life Science Podcast

25 minutes 24 seconds

10 months ago

The JCA is live

After3 years in the making, the Joint Clinical Assessment for the EU is in effect.

From 12th January 2025 new cancer medicines and advanced therapy medicinal products (ATMPs) will require a JCA across all 27 member states.

Join Owen and Georgie, along with guests Darren Callanan and Sam Morrison to discuss the main talking points of the JCA, and what to look out for when dealing with the new regulations.